Zytoprotec Secures Funds from Baxter Ventures

Posted on: January 29, 2013 by asormaniNo Comments »

Zytoprotec, a company developing novel peritoneal dialysis solutions and other treatments based on active cytoprotection, has raised 2 million euros ($2.7 million) from new investor Baxter Ventures. The funding goes towards a 4 million euros Series A financing.